{
    "2021-06-29": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Walmart aims to aid in affordable diabetes care with its private brand analog insulin",
                "features": {
                    "keywords": [
                        "Walmart",
                        "affordable diabetes care",
                        "private brand",
                        "analog insulin"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Now on Sale at Walmart: Insulin Thatâ€™s Cheaper Than Brands from Lilly, Sanofi, or Novo Nordisk",
                "features": {
                    "keywords": [
                        "Walmart",
                        "insulin",
                        "cheaper",
                        "Lilly",
                        "Sanofi",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Walmart to launch lower-priced insulin offering savings of up to 75%",
                "features": {
                    "keywords": [
                        "Walmart",
                        "lower-priced insulin",
                        "savings",
                        "75%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Walmart, Novo Nordisk Unveil Own Low-Cost Brand Insulin",
                "features": {
                    "keywords": [
                        "Walmart",
                        "Novo Nordisk",
                        "low-cost brand",
                        "insulin"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Walmart launches private label insulin brand at steep discounts for diabetes patients",
                "features": {
                    "keywords": [
                        "Walmart",
                        "private label",
                        "insulin",
                        "steep discounts",
                        "diabetes patients"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}